Starting PrEP for HIV prevention in the emergency department
Part of Infections clinical trials.
This study is testing whether starting PrEP (daily pills to prevent HIV) right away in the emergency department helps people at high risk for HIV. It aims to make it easier to start protection before you leave the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must test negative for HIV before joining
- You have asked about PrEP, or have an STI, or being tested for an STI, or your doctor thinks PrEP is right for you
- You cannot be taking PrEP now or in the last 4 weeks
- You must be willing to follow up at the Parkland ID clinic for ongoing PrEP care
- You cannot be pregnant, breastfeeding, or a prisoner
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
This study looks at ways to improve PrEP (pre-exposure prophylaxis) care by helping clinic staff track and support patients better. It's for healthcare workers, managers, and data staff at certain PrEP clinics.
This study tests a program to help men who have sex with men start and stick with PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to use and reduce HIV risk.
This study is testing a decision-support tool that helps emergency department patients learn about and start taking PrEP, a daily medicine that prevents HIV. If you are HIV negative and visiting the ER for a non-life-threatening issue, this study may help you access HIV prevention.
Hear when a new HIV Pre-exposure Prophylaxis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.